{"id":"https://openalex.org/W2164875368","doi":"https://doi.org/10.1124/jpet.110.166710","title":"Behavioral Indices in Antipsychotic Drug Discovery","display_name":"Behavioral Indices in Antipsychotic Drug Discovery","alternate_titles":[],"publication_year":2010,"publication_date":"2010-03-04","ids":{"openalex":"https://openalex.org/W2164875368","doi":"https://doi.org/10.1124/jpet.110.166710","mag":"2164875368","pmid":"https://pubmed.ncbi.nlm.nih.gov/20200119"},"language":"en","primary_location":{"id":"doi:10.1124/jpet.110.166710","doi":"https://doi.org/10.1124/jpet.110.166710","is_oa":false,"landing_page_url":"https://doi.org/10.1124/jpet.110.166710","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2164875368"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109112458","display_name":"Roger D. Porsolt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094013","display_name":"Porsolt (France)","ror":"https://ror.org/00ra8jw08","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210094013"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Roger D. Porsolt","raw_affiliation_strings":["Porsolt & Partners Pharmacology, Boulogne-Billancourt, France. rporsolt@porsolt.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Porsolt & Partners Pharmacology, Boulogne-Billancourt, France. rporsolt@porsolt.com","institution_ids":["https://openalex.org/I4210094013"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034339136","display_name":"Paul C. Moser","orcid":"https://orcid.org/0000-0002-6887-3508","observed_orcids":["https://orcid.org/0000-0002-6887-3508"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul C. Moser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5010056388","display_name":"Vincent Castagn\u00e9","orcid":"https://orcid.org/0000-0002-8728-2922","observed_orcids":["https://orcid.org/0000-0002-8728-2922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincent Castagn\u00e9","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":7.379,"has_fulltext":false,"cited_by_count":110,"citation_normalized_percentile":{"value":0.97716787,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"333","issue":"3","first_page":"632","last_page":"638"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.017400000244379044,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-drug-discovery","display_name":"antipsychotic drug discovery","score":0.9340000152587891},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9570000171661377},{"id":"https://openalex.org/keywords/rodent-models","display_name":"rodent models","score":0.593999981880188},{"id":"https://openalex.org/keywords/translational-validity","display_name":"translational validity","score":0.9200000166893005},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.8949999809265137},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.8529999852180481},{"id":"https://openalex.org/keywords/positive-symptoms","display_name":"positive symptoms","score":0.8169999718666077},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.949999988079071},{"id":"https://openalex.org/keywords/prepulse-inhibition","display_name":"prepulse inhibition","score":0.9160000085830688},{"id":"https://openalex.org/keywords/social-recognition","display_name":"social recognition","score":0.5839999914169312},{"id":"https://openalex.org/keywords/morris-water-maze","display_name":"Morris water maze","score":0.7770000100135803},{"id":"https://openalex.org/keywords/conditioned-avoidance-response","display_name":"conditioned avoidance response","score":0.6919999718666077},{"id":"https://openalex.org/keywords/parkinsonism","display_name":"parkinsonism","score":0.824999988079071},{"id":"https://openalex.org/keywords/acute-dystonia","display_name":"acute dystonia","score":0.7329999804496765},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.6990000009536743},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.8579999804496765},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.800000011920929}],"concepts":[{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6143540143966675},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.5456767678260803},{"id":"https://openalex.org/C2778941446","wikidata":"https://www.wikidata.org/wiki/Q545365","display_name":"Anhedonia","level":3,"score":0.5086622834205627},{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.5008049011230469},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4974844753742218},{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.48381227254867554},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.46282893419265747},{"id":"https://openalex.org/C128188215","wikidata":"https://www.wikidata.org/wiki/Q3026765","display_name":"Neuropharmacology","level":2,"score":0.4304657578468323},{"id":"https://openalex.org/C2780749935","wikidata":"https://www.wikidata.org/wiki/Q5141203","display_name":"Cognitive deficit","level":4,"score":0.4144088327884674},{"id":"https://openalex.org/C2780476085","wikidata":"https://www.wikidata.org/wiki/Q918193","display_name":"Catalepsy","level":4,"score":0.41210657358169556},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.40461796522140503},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.3960592746734619},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.3779042661190033},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3358699083328247},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.3134782910346985},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2750993072986603},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11417698860168457},{"id":"https://openalex.org/C2984915365","wikidata":"https://www.wikidata.org/wiki/Q5141203","display_name":"Cognitive impairment","level":3,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001519","descriptor_name":"Behavior","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003072","descriptor_name":"Cognition Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011618","descriptor_name":"Psychotic Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1124/jpet.110.166710","doi":"https://doi.org/10.1124/jpet.110.166710","is_oa":false,"landing_page_url":"https://doi.org/10.1124/jpet.110.166710","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:20200119","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20200119","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.956.3113","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.956.3113","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jpet.aspetjournals.org/content/333/3/632.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W396716130","https://openalex.org/W1512804011","https://openalex.org/W1514978607","https://openalex.org/W1545946068","https://openalex.org/W1964763649","https://openalex.org/W1979996794","https://openalex.org/W1981219005","https://openalex.org/W1985254321","https://openalex.org/W1985745091","https://openalex.org/W1986645031","https://openalex.org/W1989269561","https://openalex.org/W1993266955","https://openalex.org/W1997347471","https://openalex.org/W2000030766","https://openalex.org/W2009352908","https://openalex.org/W2012105955","https://openalex.org/W2013991313","https://openalex.org/W2015572911","https://openalex.org/W2017267321","https://openalex.org/W2018385636","https://openalex.org/W2027320268","https://openalex.org/W2029210400","https://openalex.org/W2032193303","https://openalex.org/W2035601252","https://openalex.org/W2036024568","https://openalex.org/W2036283124","https://openalex.org/W2045754651","https://openalex.org/W2048079797","https://openalex.org/W2063505213","https://openalex.org/W2068337150","https://openalex.org/W2069234476","https://openalex.org/W2080357839","https://openalex.org/W2083445063","https://openalex.org/W2084685054","https://openalex.org/W2089299823","https://openalex.org/W2092099312","https://openalex.org/W2095457266","https://openalex.org/W2104547788","https://openalex.org/W2112739763","https://openalex.org/W2142885788","https://openalex.org/W2162845180","https://openalex.org/W2165843693","https://openalex.org/W2259599448","https://openalex.org/W2411296754","https://openalex.org/W2490201800","https://openalex.org/W2496203087","https://openalex.org/W4241804791","https://openalex.org/W6723788451"],"related_works":["https://openalex.org/W1512804011","https://openalex.org/W2114176302","https://openalex.org/W1490681631","https://openalex.org/W4223417044","https://openalex.org/W7160064374","https://openalex.org/W2105627946","https://openalex.org/W7117109336","https://openalex.org/W125841314","https://openalex.org/W2033428309"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2164875368","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
